| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate |
2004-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2009-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-100549006-C |
| titleOfInvention |
The mitotic kinesins inhibitor |
| abstract |
The present invention relates to be effective to treat cell proliferation disorders, be used for the treatment of and suppress the pyrroline compound of the formula (I) of KSP kinesin with the active relevant obstacle of KSP kinesin.The invention still further relates to and contain these compound compositions and utilize them to treat mammiferous method for cancer. |
| priorityDate |
2003-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |